Thank you for this review of RSV vaccines for children. It sounds like a very tenuous persuit for a vaccine application where better solutions are available.
The treatment you note, monochromal antibodies, were an early part of covid answers. My recollection is they stopped when the disease evolution outstripped their effectiveness. I not…
Thank you for this review of RSV vaccines for children. It sounds like a very tenuous persuit for a vaccine application where better solutions are available.
The treatment you note, monochromal antibodies, were an early part of covid answers. My recollection is they stopped when the disease evolution outstripped their effectiveness. I noted today that 4 variations stockpiled are finally scheduled for destruction.
My impression is you are suggesting that GSK, Pfizer and Moderna are pursuing vax solutions in hopes of securing participation in the childhood schedule. I hope they are not doing this with grant monies.
Personally. particularly at a time when the efficacy of the entries on the Childhood Schedule are being considered for review, I'd prefer a focus on identifying effective preventative measures and treatments.
As for vaccinations for the elderly, I personally would need a very compelling argument of need, full disclosure of risks and an option to decline. I'm a very hard sell! My Dr. seems to recognize that. No more mentions of the word 'vaccine' passes our lips any more.
Thanks so much for your share and helpful observations!
Thank you for this review of RSV vaccines for children. It sounds like a very tenuous persuit for a vaccine application where better solutions are available.
The treatment you note, monochromal antibodies, were an early part of covid answers. My recollection is they stopped when the disease evolution outstripped their effectiveness. I noted today that 4 variations stockpiled are finally scheduled for destruction.
My impression is you are suggesting that GSK, Pfizer and Moderna are pursuing vax solutions in hopes of securing participation in the childhood schedule. I hope they are not doing this with grant monies.
Personally. particularly at a time when the efficacy of the entries on the Childhood Schedule are being considered for review, I'd prefer a focus on identifying effective preventative measures and treatments.
As for vaccinations for the elderly, I personally would need a very compelling argument of need, full disclosure of risks and an option to decline. I'm a very hard sell! My Dr. seems to recognize that. No more mentions of the word 'vaccine' passes our lips any more.
Thanks so much for your share and helpful observations!